Labcorp Holdings Inc.
$360.47
+0.21 · +0.06% today
Market open · updated 12:45:29 PM ET
- High
- $368.01 5:00 AM
- Low
- $363.02 4:40 AM
Against the S&P 500 Price change through Oct 28, 2026
LH+43.59%
S&P 500+13.26%
LH+38.72%
S&P 500+12.41%
LH+81.07%
S&P 500+88.06%
LH+47.02%
S&P 500+68.51%
Key numbers
- Previous close
- $360.25
- Open
- $355.94
- Day's range
- $351.59 – $363.81
- 52-week range
- $244.52 – $371.00
- Volume
- 342,162
- Average volume
- 713,424
- Market value
- $29.2 billion
- Price to earnings
- 29.4last 12 months
- Earnings per share
- $12.38last 12 months
- Beta
- 0.85moves less than the market
- Dividend
- $2.88 a year · 0.80%
- 50-day average
- $321.90
- 200-day average
- $286.48
Analyst price targets and the full financials are in the terminal.
Who Labcorp competes with From our value chain
Labcorp in the news
- Market closeS&P 500, Dow, Nasdaq Close Higher as Fed Holds Rates SteadyWiseView Research desk · October 28, 2026
- HeadlineLabcorp Holdings Inc. (LH) Q3 2026 Earnings Call TranscriptSeeking Alpha · October 28, 2026 at 2:50 PM ET
- HeadlineLabcorp Q3 Earnings Call HighlightsMarketBeat · October 28, 2026 at 1:05 PM ET
- HeadlineLH Stock Rises on Q3 Earnings and Revenue Beat, '26 View UpZacks Investment Research · October 28, 2026 at 11:26 AM ET
- HeadlineCompared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key MetricsZacks Investment Research · October 28, 2026 at 10:31 AM ET
- HeadlineLabcorp Holdings (LH) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research · October 28, 2026 at 9:36 AM ET
- HeadlineLabcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 GuidancePRNewsWire · October 28, 2026 at 6:50 AM ET
- HeadlineLabcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse PotentialPRNewsWire · October 22, 2026 at 4:30 PM ET
Congress trades in LH
4 purchases and 4 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 4, 2026 | Oct 9, 2026 |
| April McClain DelaneyHouse · D-Maryland | Sale | $100,001 - $250,000 | Aug 25, 2026 | Sep 10, 2026 |
| April McClain DelaneyHouse · D-Maryland | Sale | $1,001 - $15,000 | Aug 7, 2026 | Sep 10, 2026 |
| April McClain DelaneyHouse · D-Maryland | Sale | $1,001 - $15,000 | Aug 6, 2026 | Sep 10, 2026 |
| April McClain DelaneyHouse · D-Maryland | Sale | $1,001 - $15,000 | Aug 5, 2026 | Sep 10, 2026 |
| Tony WiedHouse · R-Wisconsin | Purchase | $15,001 - $50,000 | Feb 19, 2026 | Mar 12, 2026 |
| April McClain DelaneyHouse · D-Maryland | Purchase | $1,001 - $15,000 | Feb 11, 2026 | Mar 11, 2026 |
| April McClain DelaneyHouse · D-Maryland | Purchase | $1,001 - $15,000 | Feb 4, 2026 | Mar 11, 2026 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Labcorp
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 71,000
- Headquarters
- Burlington, North Carolina
- Website
- labcorp.com
- Listed
- Mar 29, 1990
More medical - diagnostics & research stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.